FDA Announces New Steps to Develop Evidence-Based Guidelines for Opioid Prescribing
FDA Commissioner Scott Gottlieb gives a statement on new steps to advance the development of evidence-based, indication-specific guidelines to help guide appropriate prescribing of opioid analgesics.
